Breast Cancer Breakthroughs Episode 3: Highlights from ASCO 2023
The latest advances in breast cancer research were recently announced at the American Society of Clinical Oncology 2023 Annual Meeting. In this episode of Br…
Related Articles
Earlier breast cancer screening could save ‘20% more lives’
Screening earlier and more often could be especially beneficial for Black women, who are 40% more likely to die of breast cancer than white women.
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial
DESTINY-Breast03 is a randomized, multicenter, open-label, phase III study of trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients with human epidermal growth factor receptor…
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published…
Major Shift in Recommendations for Germline Testing in Breast Cancer
New breast cancer recommendations call for BRCA1/2 mutation testing in all newly diagnosed patients aged 65 years or younger and certain older patients.
Is Vaccination Approaching a Dangerous Tipping Point?
This Viewpoint discusses declining vaccination rates in the US, specifically against COVID-19, and the ways in which clinicians and the Food and Drug Administration can…
